Genetic testing in myelodysplastic syndromes contribution in diagnosis, prognostic and clinical management
Myelodysplastic syndromes (MDS) represent a group of clonal hematological malignancies characterized by ineffective hematopoiesis. Other hematological disorders associating dysplastic features are grouped under the myelodysplastic/ myeloproliferative neoplasms (MDS/MPN) category. The great diversity...
Main Authors: | Aurora Arghir, Sorina Mihaela Chirieac, Nicoleta Berbec, Oana Ciocan, Andreea Cristina Tutulan-Cunita, Agripina Lungeanu |
---|---|
Format: | Article |
Language: | English |
Published: |
"Alexandru Ioan Cuza" University of Iași
2010-06-01
|
Series: | Analele Ştiinţifice Ale Universităţii Alexandru Ioan Cuza din Iași,Sectiunea II A : Genetica si Biologie Moleculara |
Online Access: | http://www.gbm.bio.uaic.ro/index.php/gbm/article/view/746 |
Similar Items
-
Microarray-based comparative genomic hybridization (aCGH) between basic research and clinical diagnostic
by: Andreea Cristina Tutulan-Cunita, et al.
Published: (2010-06-01) -
Rare hematologic neoplasms an acute megakaryocytic leukemia case report
by: Sorina Mihaela Chiriac, et al.
Published: (2010-06-01) -
Molecular characterization of complex chromosomal changes in de novo acute myeloid leukemia: a case report
by: Berbec Nicoleta P., et al.
Published: (2013-03-01) -
The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis
by: Tatic Aurelia, et al.
Published: (2013-09-01) -
Prognostic Markers of Myelodysplastic Syndromes
by: Yuliya Andreevna Veryaskina, et al.
Published: (2020-07-01)